Track Neogen Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Neogen Corporation NEOG · Stock Open Neogen Corporation in new tab

13.00 USD
Add to portfolio
EPS
-0.04
P/B
1.23
ROE
-0.38
Beta
1.76
Target Price
13.33 USD
Neogen Corporation logo

Neogen Corporation

🧾 Earnings Recap – Q4 2025

Neogen Corporation's fourth quarter results reflect ongoing challenges in the Food Safety segment, compounded by market and regulatory pressures. However, strategic initiatives in pathogen detection and operational simplification signal a focused path forward.

  • Food Safety end market conditions worsened due to ongoing inflation pressures, leading to lower production volumes among food producers.
  • Neogen launched the Listeria Right Now assay on its MDS platform, enhancing pathogen detection capabilities.
  • The Board is transitioning the CEO role to better align with future growth potential amidst a regulatory environment prioritizing food safety.
  • Core revenue in the Animal Safety segment has faced headwinds, but signs of improvement in net farm incomes could support recovery.
  • Ongoing divestiture processes aim to streamline operations and prioritize core business areas for improved focus and deleveraging.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateOct. 8, 2026
EPS-0.04
Book Value9.61
Price to Book1.23
Debt/Equity38.83
% Insiders0.705%
Growth
Revenue Growth0.00%
Estimates
Forward P/E31.00
Forward EPS0.38
Target Mean Price13.33

DCF Valuation

Tweak assumptions to recompute fair value for Neogen Corporation (NEOG)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Neogen Corporation Logo Neogen Corporation Analysis (NEOG)

United States Health Care Official Website Stock

Is Neogen Corporation a good investment? Neogen Corporation (NEOG) is currently trading at 13.00 USD. Market analysts have a consensus price target of 13.33 USD. This suggests a potential upside from current levels.

Earnings Schedule: Neogen Corporation is expected to release its next earnings report on Oct. 8, 2026. The market consensus estimate for Forward EPS is 0.38.

Investor FAQ

Does Neogen Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Neogen Corporation?

Neogen Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Oct. 8, 2026. The company currently has a trailing EPS of -0.04.

Company Profile

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Exchange Ticker
NMS (United States) NEOG
FRA (Germany) NG2.F
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 2, 2004 1.25
Sept. 5, 2007 1.5
Dec. 16, 2009 1.5
Oct. 31, 2013 1.5
Jan. 2, 2018 1.33
June 7, 2021 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion